Tag: Cancer: Lung
Lorlatinib Superior to Crizotinib for ALK-Positive NSCLC
Interim analysis shows risk for disease progression or death lower for first-line therapy with lorlatinib versus crizotinib
Use of Common Meds Tied to Lower Lung Cancer Mortality
Combined use of aspirin, statins, metformin tied to lower lung cancer risk and mortality
Atezolizumab Prolongs Survival in NSCLC With PD-L1 Expression
Overall survival longer than for chemotherapy in metastatic NSCLC with high PD-L1 expression
Lung Cancer Treatment Plans Changed Due to Pandemic
57 percent of patients receiving active treatment had at least one change in treatment plans
Respiratory, Lung Cancer Death Up Even With Low-Intensity Smoking
Risks for respiratory and lung cancer mortality increased for those smoking <10 cigarettes per day
Model Better Predicts Lung Cancer Risk for African Americans
Sensitivity for lung cancer screening greater with PLCOm2012 model than USPSTF criteria
AI Model Using Chest X-Ray May Predict 12-Year Lung Cancer Risk
CXR-LC model had better discrimination than CMS eligibility, similar performance to PLCO Model 2012
Black-White Disparity in Lung Cancer Incidence Eliminated
Historical trend of increased incidence in Blacks versus Whites disappeared in men, reversed in women
Sharp Drop in Non-Small Cell Lung Cancer Mortality Seen in Recent Years
Reduction in incidence plus treatment advances explain the reduction in mortality
USPSTF Advises Annual Low-Dose CT Lung Screening for High-Risk Individuals
Annual CT screening recommended for those aged 50 to 80 years at high risk due to smoking history
